纳斯达克 -- -- --

最近浏览

众巢医学

NASDAQ:ZCMD 延时15分钟
  • 今开:--
    昨收:--
  • 今日区间:--
    52周区间:--
  • 成交量:--
    成交额:--
  • 市 值:--
    市盈率:--
  • 振幅:
    每股收益:
成交量

董事会

Wei Guang Yang
Wei Guang Yang is the founder of Zhongchao, Inc. and Zhongchao Medical Technology (Shanghai) Corp., both founded in 2012. He held the titles of Chairman, President & Chief Executive Officer and General Manager respectively. Mr. Yang's former jobs include Co-Chief Executive Officer & Director at TradeUP Acquisition Corp., Director at Global Alliance For Medical Education from 2013 to 2016, and General Manager at MedWorks Corp. from 2005 to 2012. Mr. Yang received his undergraduate degree from Gannan Medical University in 2005 and his graduate degree from Capital Medical University in 2008.
Pei Xu
Pei Xu is the founder of Zhongchao, Inc., founded in 2019, serving as Chief Financial Officer, Secretary & Director. Current jobs include Independent Director at Estrella Immunopharma, Inc., and Chief Financial Officer at Zhongchao Medical Technology (Shanghai) Corp. since 2016. Former job includes Financial Director at Otsuka (China) Investment Co., Ltd. from 2008 to 2013. Education includes an undergraduate degree from Jiangxi University of Finance & Economics.
John Conrad General
John Conrad General currently works at Zhongchao, Inc., as Independent Director from 2019. Mr. General also formerly worked at AT&T Corp., as Financial Director from 1986 to 2003, 20230930-DK-Butterfly-1, Inc., as Manager-Financial Operations from 2010 to 2013, and Value Services, Inc., as Manager-Financial Operations from 2010 to 2013. Mr. General received his Masters Business Admin degree from Rutgers State University of New Jersey and undergraduate degree from Fairleigh Dickinson University.
Kevin Dean Vassily
Mr. Kevin D. Vassily is an Independent Director at CTW, an Independent Director at Autozi Internet Technology (Global) Ltd., an Independent Director at Thunder Power Holdings, Inc., an Independent Director at Tungray Technologies, Inc., an Independent Director at Aimfinity Investment Corp. I, an Independent Director at Fortune Joy International Acquisition Corp., an Independent Director at Zhongchao, Inc. and an Independent Director at Inkstone Feibo Acquisition Corp. He is on the Board of Directors at CTW, Autozi Internet Technology (Global) Ltd., Thunder Power Holdings, Inc., Tungray Technologies, Inc., Aimfinity Investment Corp. I, Fortune Joy International Acquisition Corp., Zhongchao, Inc., Autozi Lianhe E-Commerce (Beijing) Co., Ltd. and Inkstone Feibo Acquisition Corp. Mr. Vassily was previously employed as an Independent Director by Feutune Light Acquisition Corp., an Independent Director by Denali Capital Acquisition Corp., a Chief Financial Officer by iPower, Inc., a Vice President-Market Development by Facteus, Inc., an Associate Director-Research by KeyBanc Capital Markets, Inc., a Research Director by Pacific Epoch, an Associate Director of Research by Pacific Crest Securities LLC, a Senior Research Analyst by Susquehanna Financial Group LLLP, a Senior Research Analyst by Susquehanna International Group LLP, a Vice President & Senior Research Analyst by Thomas Weisel Partners, a Vice President by Thomas Weisel Partners LLC, a Financial Analyst by Applied Materials, Inc., and a Research Associate by Lehman Brothers Real Estate Group. He received his undergraduate degree from Denison University and an MBA from Tuck School of Business at Dartmouth.
Dan Li
Dan Li currently works at Zhongchao, Inc., as Independent Director from 2019. Dr. Li also formerly worked at EPS Holdings, Inc., as Manager-Medicine Management Department from 2009 to 2011. Dr. Li received her doctorate degree from Keio University, graduate degree from Peking University, and undergraduate degree from North China University of Science & Technology.
美股基本数据由天汇财经提供,免责声明:天汇财经、Factset及其他信息供应商努力确保所提供信息的准确性和可靠性,但对于其正确性或可靠性则不予担保,且对于因不正确或疏漏所造成的任何损失或损坏概不负责(无论是有关民事过失、合同或其他方面)。